UC(ulcerative colitis)
Conditions
Interventions
Case series:NA
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who met the diagnosis of ulcerative colitis and took Five-Flavor Sophora Flavescens enteric-coated capsule since August 2018; 2.No age limit, no gender limit; 3.The treatment course of Five-Flavor Sophora Flavescens enteric-coated capsule was more than half a year; 4.In the process of patients using Five-Flavor Sophora Flavescens enteric coated capsules, the indicators of clinical efficacy that can be evaluated include: at least one clinical symptom evaluation every 3-6 months; Inflammatory markers (ESR, CRP/HsCRP) were evaluated at least once every 3 to 6 months; At least 1 colonoscopy evaluation every 6 months to 1 year. 5.In the process of using Five-Flavor Sophora Flavescens enteric-coated capsules, the indicators for safety evaluation include: at least 1-2 blood routine and liver and kidney function tests every six months, and at least 2-3 blood routine and liver and kidney function tests every year.
Exclusion criteria
Exclusion criteria: 1.discontinuous application of Five-Flavor Sophora Flavescens enteric capsules or combined use of Five-Flavor Sophora Flavescens enteric capsules dose does not meet the requirements; 2.Patients with two or more drugs for ulcerative colitis; 3.According to the judgment of the researcher, it is not appropriate to participate in this researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fecal bleeding score;blood routine;biochemical indicators;Inflammatory indicators;colonoscopy;CAI score;Mayo score;number of stools;biochemical indicators; | — |
Countries
China
Contacts
Public ContactHong Yang
Peking Union Medical College Hospital
Outcome results
None listed